108 related articles for article (PubMed ID: 15909814)
1. [Alpha-fetoprotein immunotherapy as a stage of combined treatment of cancer patients].
Chereshnev VA; Rodionov SIu; Vasil'ev NV; Orlov OA; Cherkasov VA
Vopr Onkol; 2005; 51(1):86-92. PubMed ID: 15909814
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
3. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
4. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3.
Irony-Tur-Sinai M; Grigoriadis N; Tsiantoulas D; Touloumi O; Abramsky O; Brenner T
J Neurol Sci; 2009 Apr; 279(1-2):80-7. PubMed ID: 19171355
[TBL] [Abstract][Full Text] [Related]
6. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
7. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
Sbiera S; Wortmann S; Fassnacht M
Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
10. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Yang X; Zhang Y; Zhang L; Zhang L; Mao J
Cancer Lett; 2008 Nov; 271(2):281-93. PubMed ID: 18657899
[TBL] [Abstract][Full Text] [Related]
11. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
12. Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organs.
Kamoshida S; Suzuki M; Sakurai Y; Ochiai M; Kimura F; Kuwao S; Sakamoto K; Sugimoto Y; Fukushima M; Tsutsumi Y
Oncol Rep; 2006 Oct; 16(4):721-7. PubMed ID: 16969485
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy combined with chemotherapy in the treatment of tumors.
Frazier JL; Han JE; Lim M; Olivi A
Neurosurg Clin N Am; 2010 Jan; 21(1):187-94. PubMed ID: 19944977
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
[TBL] [Abstract][Full Text] [Related]
16. Witch hunt against tumor cells enhanced by dendritic cells.
Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
Dudich E; Semenkova L; Dudich I; Denesyuk A; Tatulov E; Korpela T
FEBS J; 2006 Aug; 273(16):3837-49. PubMed ID: 16869888
[TBL] [Abstract][Full Text] [Related]
18. alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Li M; Zhou S; Liu X; Li P; McNutt MA; Li G
Cancer Lett; 2007 May; 249(2):227-34. PubMed ID: 17046153
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression.
Huang J; Wang Y; Guo J; Lu H; Lin X; Ma L; Teitz-Tennenbaum S; Chang AE; Li Q
Clin Immunol; 2007 Jun; 123(3):298-310. PubMed ID: 17449328
[TBL] [Abstract][Full Text] [Related]
20. The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Pak VN
Ther Deliv; 2018 Jan; 9(1):37-46. PubMed ID: 29216804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]